Armstrong chose Indiana because its oncologists said they could treat him without bleomycin, a type of chemotherapy that would have damaged his lungs and ended his cycling career if he survived.
Armstrong eligió ese centro de Indiana porque sus oncólogos dijeron que podían tratarlo sin bleomicina, un tipo de quimioterapia que, si sobrevivía, podía dañarle los pulmones y poner fin a sus carrera de ciclista.